Home » Reports » Broker Ratings » AstraZeneca plc 14.5% Potential Decrease Indicated by HSBC
Analyst Broker Ratings

AstraZeneca plc 14.5% Potential Decrease Indicated by HSBC

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘REDUCE’ today by analysts at HSBC. AstraZeneca plc are listed in the Health Care sector within UK Main Market. HSBC have set a target price of 5180 GBX on its stock. This now indicates the analyst believes there is a potential downside of -14.5% from the opening price of 6060 GBX. Over the last 30 and 90 trading days the company share price has decreased 152 points and increased 203 points respectively. The 1 year high stock price is 6540 GBX while the year low share price is currently 4825 GBX.

AstraZeneca plc has a 50 day moving average of 6,076.08 GBX and a 200 Day Moving Average share price is recorded at 5,923.34. There are currently 1,267,368,885 shares in issue with the average daily volume traded being 2,631,554. Market capitalisation for LON:AZN is £77,372,870,429 GBP.